Trupanion, Inc. (TRUP) 10-Year Financial Performance & Capital Metrics

TRUP • • Insurance & Managed Care

Financial ServicesSpecialty InsuranceSpecialty Property & Casualty InsurancePet Insurance Providers

AboutTrupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. The company was founded in 2000 and is headquartered in Seattle, Washington.Show more

Revenue $1.29B +16.0%
Combined Ratio 100.74% -2.8%
Net Income -$10M +78.4%
Return on Equity -3.07% +79.1%
Medical Cost Ratio 86.09% -2.4%
Operating Margin -0.74% +79.8%
Net Margin -0.75% +81.4%
ROA -1.21% +80.3%
Equity / Assets 40.07% +3.3%
Book Value per Share 7.67 +4.6%
Tangible BV/Share 6.48 +11.3%
Debt/Equity 0.40 -6.1%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong Piotroski F-Score: 7/9

✗Weaknesses

✗Weak momentum: RS Rating 19 (bottom 19%)
✗High loss ratio of 86.1%
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y27.2%

5Y27.34%

3Y22.52%

TTM12.5%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM214.92%

EPS CAGR

10Y-

5Y-

3Y-

TTM211.27%

ROCE

10Y Avg-8.39%

5Y Avg-7.23%

3Y Avg-7.99%

Latest-2.12%

Peer Comparison

Pet Insurance Providers

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
TRUPTrupanion, Inc.	1.46B	33.91	-147.43	15.97%	1.1%	4.19%	2.63%	0.40

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Revenue+	146.96M	188.23M	242.67M	303.96M	383.94M	502.03M	698.99M	905.18M	1.11B	1.29B
Revenue Growth %	0.27%	0.28%	0.29%	0.25%	0.26%	0.31%	0.39%	0.29%	0.22%	0.16%
Medical Costs & Claims+	121.73M	154.94M	199.62M	252.59M	319.01M	420.13M	594.64M	782.99M	977.59M	1.11B
Medical Cost Ratio %	-	-	-	-	-	-	-	-	-	-
Gross Profit+	25.23M	33.29M	43.05M	51.37M	64.92M	81.9M	104.35M	122.19M	131.02M	178.8M
Gross Margin %	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	0.27%	0.32%	0.29%	0.19%	0.26%	0.26%	0.27%	0.17%	0.07%	0.36%
Operating Expenses+	42M	39.99M	45.69M	52.41M	66.84M	86.83M	139.54M	165.19M	171.68M	188.31M
OpEx / Revenue %	-	-	-	-	-	-	-	-	-	-
Depreciation & Amortization	2.54M	3.85M	4.23M	4.51M	5.63M	7.07M	11.96M	10.92M	12.47M	16.47M
Combined Ratio %	-	-	-	-	-	-	-	-	-	-
Operating Income+	-16.77M	-6.7M	-2.64M	-1.04M	-1.92M	-4.93M	-35.2M	-43M	-40.66M	-9.51M
Operating Margin %	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	-0.05%	0.6%	0.61%	0.6%	-0.84%	-1.57%	-6.14%	-0.22%	0.05%	0.77%
EBITDA+	-14.23M	-2.85M	1.59M	3.47M	3.71M	2.14M	-23.23M	-32.08M	-28.18M	6.95M
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-
Interest Expense	325K	218K	533K	1.2M	1.35M	1.38M	10K	4.27M	12.08M	14.5M
Non-Operating Income	-9K	-58K	-1.24M	-1.31M	-1.63M	-581K	14K	-3.07M	-7.7M	-14.37M
Pretax Income+	-17.09M	-6.86M	-1.93M	-934K	-1.64M	-5.73M	-35.22M	-44.2M	-45.03M	-9.64M
Pretax Margin %	-	-	-	-	-	-	-	-	-	-
Income Tax+	114K	38K	-428K	-7K	169K	113K	310K	476K	-342K	-5K
Effective Tax Rate %	-	-	-	-	-	-	-	-	-	-
Net Income+	-17.2M	-6.9M	-1.5M	-927K	-1.81M	-5.84M	-35.53M	-44.67M	-44.69M	-9.63M
Net Margin %	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	0.19%	0.6%	0.78%	0.38%	-0.95%	-2.23%	-5.08%	-0.26%	-0%	0.78%
EPS (Diluted)+	-0.62	-0.24	-0.05	-0.03	-0.05	-0.16	-0.89	-1.10	-1.08	-0.23
EPS Growth %	0.18%	0.61%	0.79%	0.43%	-0.8%	-2.07%	-4.56%	-0.24%	0.02%	0.79%
EPS (Basic)	-0.62	-0.24	-0.05	-0.03	-0.05	-0.16	-0.89	-1.10	-1.08	-0.23
Diluted Shares Outstanding	27.64M	28.53M	29.59M	31.96M	34.65M	35.86M	40.14M	40.77M	41.44M	42.16M

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Assets+	70.92M	82.34M	105.86M	207.51M	257.2M	498.25M	562.58M	671.63M	782.95M	806.85M
Asset Growth %	-0.28%	0.16%	0.29%	0.96%	0.24%	0.94%	0.13%	0.19%	0.17%	0.03%
Total Investment Assets+	27.98M	32.42M	40.83M	58.11M	74.06M	95.43M	133.07M	164.65M	142.53M	147.46M
Long-Term Investments	2.69M	2.85M	3.24M	3.55M	4.32M	5.57M	7.06M	7.84M	12.87M	373K
Short-Term Investments	25.29M	29.57M	37.59M	54.56M	69.73M	89.86M	126.01M	156.8M	129.67M	147.09M
Total Current Assets+	53.63M	65.39M	86.56M	117.98M	158.82M	337.03M	390.95M	469.1M	562.09M	597.33M
Cash & Equivalents	17.96M	23.64M	25.71M	26.55M	29.17M	139.88M	87.4M	65.61M	147.5M	160.29M
Receivables	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Assets	0	0	0	0	0	0	0	14.25M	17.02M	15.91M
Goodwill & Intangibles+	4.85M	4.91M	4.97M	8.07M	7.73M	60.18M	55.37M	66.01M	62.46M	50.15M
Goodwill	0	0	0	0	0	33.05M	32.71M	41.98M	43.71M	36.97M
Intangible Assets	4.85M	4.91M	4.97M	8.07M	7.73M	27.13M	22.66M	24.03M	18.75M	13.18M
PP&E (Net)	9.72M	8.46M	7.87M	69.8M	70.37M	72.6M	77.95M	90.7M	103.65M	102.19M
Other Assets	23K	734K	3.22M	8.11M	15.95M	22.88M	31.25M	37.98M	41.88M	56.81M
Total Liabilities	25.56M	37.63M	57.42M	78.34M	120.44M	158.31M	230.38M	366.33M	479.23M	483.58M
Total Debt+	0	4.77M	9.32M	12.86M	26.09M	0	0	69.46M	128.93M	128.89M
Net Debt	-17.96M	-18.87M	-16.38M	-13.69M	-3.08M	-139.88M	-87.4M	3.85M	-18.57M	-31.41M
Long-Term Debt	0	4.77M	9.32M	12.86M	26.09M	0	0	68.35M	127.58M	127.54M
Short-Term Debt	0	0	0	0	0	0	0	1.1M	1.35M	1.35M
Total Current Liabilities+	23.62M	30.66M	45.87M	63.2M	91.63M	150.4M	223.7M	289.62M	344.47M	349.63M
Accounts Payable	1.29M	2.01M	2.72M	2.77M	4.09M	6.06M	8.95M	9.47M	10.51M	11.53M
Deferred Revenue	11.04M	13.46M	22.73M	33.03M	52.55M	92.55M	146.91M	202.69M	235.33M	251.64M
Other Current Liabilities	6.44M	-20.89M	12.76M	16.06M	21.19M	28.93M	39.67M	43.73M	63.24M	85.1M
Deferred Taxes	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Liabilities	1.77M	32.61M	1.23M	1.27M	1.61M	3.21M	3.86M	4.97M	4.49M	4.48M
Total Equity+	45.36M	44.72M	48.43M	129.17M	136.76M	339.94M	332.2M	305.3M	303.72M	323.27M
Equity Growth %	-0.23%	-0.01%	0.08%	1.67%	0.06%	1.49%	-0.02%	-0.08%	-0.01%	0.06%
Shareholders Equity	45.36M	44.72M	48.43M	129.17M	136.76M	339.94M	332.2M	305.3M	303.72M	323.27M
Minority Interest	0	0	0	0	0	0	0	0	0	0
Retained Earnings	-74.39M	-81.28M	-82.78M	-83.71M	-85.52M	-91.36M	-126.89M	-171.56M	-216.25M	-225.89M
Common Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-502K	-377K	-92K	-753K	250K	3.07M	3.08M	-6.3M	403K	-2.61M
Return on Equity (ROE)	-0.33%	-0.15%	-0.03%	-0.01%	-0.01%	-0.02%	-0.11%	-0.14%	-0.15%	-0.03%
Return on Assets (ROA)	-0.2%	-0.09%	-0.02%	-0.01%	-0.01%	-0.02%	-0.07%	-0.07%	-0.06%	-0.01%
Equity / Assets	-	-	-	-	-	-	-	-	-	-
Debt / Equity	-	0.11x	0.19x	0.10x	0.19x	-	-	0.23x	0.42x	0.40x
Book Value per Share	1.64	1.57	1.64	4.04	3.95	9.48	8.28	7.49	7.33	7.67
Tangible BV per Share	-	-	-	-	-	-	-	-	-	-

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-10.43M	5.01M	9.67M	12.68M	16.16M	21.54M	7.46M	-8M	18.64M	48.29M
Operating CF Growth %	0.03%	1.48%	0.93%	0.31%	0.27%	0.33%	-0.65%	-2.07%	3.33%	1.59%
Operating CF / Revenue %	-	-	-	-	-	-	-	-	-	-
Net Income	-17.2M	-6.9M	-1.5M	-927K	-1.81M	-5.84M	-35.53M	-44.67M	-44.69M	-9.63M
Depreciation & Amortization	2.54M	3.85M	4.23M	4.51M	5.63M	7.07M	11.96M	10.92M	12.47M	16.47M
Stock-Based Compensation	3M	2.95M	3.42M	4.78M	6.85M	8.91M	28.23M	33.39M	33.16M	33.43M
Deferred Taxes	0	0	-1.04M	0	0	0	0	0	0	0
Other Non-Cash Items	-68K	104K	-383K	-240K	105K	153K	-1.93M	1.05M	1.35M	3.55M
Working Capital Changes	1.3M	5.01M	4.94M	4.56M	5.38M	11.25M	4.72M	-8.69M	16.35M	4.47M
Cash from Investing+	-9.92M	-6.51M	-13.06M	-81.45M	-28.01M	-76.75M	-51.91M	-67.52M	7.64M	-13.46M
Capital Expenditures	-4.89M	-1.94M	-3.13M	-59.9M	-5.37M	-7.45M	-12.36M	-17.09M	-18.28M	-9.72M
Acquisitions	-300K	0	1.4M	2.96M	0	-48.13M	0	-15.03M	0	0
Purchase of Investments	-24.8M	-31.62M	-31.92M	-55.86M	-69.51M	-65.29M	-95.67M	-273.01M	-165.94M	-133.49M
Sale/Maturity of Investments	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Investing	-109K	-198K	-2.78M	-4.07M	-2.89M	57K	-1.75M	-1.6M	1.58M	2.1M
Cash from Financing+	-14.21M	7.67M	5.08M	71.23M	14.04M	170.85M	-1.13M	60.74M	59.13M	-3.96M
Dividends Paid	0	0	0	0	0	0	0	-6.94M	0	0
Share Repurchases	-643K	-662K	-1.17M	-1.84M	-1.67M	-1.11M	-4.73M	-5.75M	-1.54M	-2.52M
Stock Issued	1.33M	0	0	65.67M	0	192.26M	3.61M	0	0	0
Debt Issuance (Net)	-1000K	1000K	1000K	1000K	1000K	-1000K	0	1000K	1000K	-1000K
Other Financing	692K	3.35M	1.85M	3.97M	2.54M	5.93M	0	9.23M	2.28M	-88K
Net Change in Cash+	-35.14M	6.28M	2.07M	1.65M	2.62M	115.63M	-45.33M	-16.23M	85.83M	29.07M
Exchange Rate Effect	-586K	111K	378K	-812K	423K	-16K	252K	-1000K	424K	-1000K
Cash at Beginning	53.1M	17.96M	24.24M	26.31M	27.95M	30.57M	146.2M	100.87M	84.64M	170.46M
Cash at End	17.96M	24.24M	26.31M	27.95M	30.57M	146.2M	100.87M	84.64M	170.46M	199.53M
Free Cash Flow+	-15.32M	3.06M	6.54M	-47.22M	10.78M	14.09M	-4.9M	-25.09M	358K	38.57M
FCF Growth %	0.07%	1.2%	1.13%	-8.22%	1.23%	0.31%	-1.35%	-4.12%	1.01%	106.74%
FCF Margin %	-	-	-	-	-	-	-	-	-	-
FCF per Share	-0.55	0.11	0.22	-1.48	0.31	0.39	-0.12	-0.62	0.01	0.91

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Combined Ratio	111.41%	103.56%	101.09%	100.34%	100.5%	100.98%	105.04%	104.75%	103.67%	100.74%
Medical Cost Ratio	82.83%	82.32%	82.26%	83.1%	83.09%	83.69%	85.07%	86.5%	88.18%	86.09%
Return on Equity (ROE)	-32.89%	-15.31%	-3.23%	-1.04%	-1.36%	-2.45%	-10.57%	-14.01%	-14.68%	-3.07%
Return on Assets (ROA)	-20.33%	-9%	-1.6%	-0.59%	-0.78%	-1.55%	-6.7%	-7.24%	-6.15%	-1.21%
Equity / Assets	63.96%	54.3%	45.75%	62.25%	53.17%	68.23%	59.05%	45.46%	38.79%	40.07%
Book Value / Share	1.64	1.57	1.64	4.04	3.95	9.48	8.28	7.49	7.33	7.67
Debt / Equity	-	0.11x	0.19x	0.10x	0.19x	-	-	0.23x	0.42x	0.40x
Revenue Growth	26.79%	28.08%	28.92%	25.26%	26.31%	30.76%	39.23%	29.5%	22.47%	15.97%

Revenue by Segment

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Subscription business	133.41M	173.36M	218.35M	263.74M	321.16M	387.73M	494.86M	596.61M	712.91M	856.52M
Subscription business Growth	-	29.95%	25.96%	20.78%	21.77%	20.73%	27.63%	20.56%	19.49%	20.15%
Other Operating	-	-	-	-	-	-	-	-	-	429.16M
Other Operating Growth	-	-	-	-	-	-	-	-	-	-
Others	13.56M	14.87M	24.31M	40.22M	62.77M	114.3M	204.13M	308.57M	395.7M	-
Others Growth	-	9.71%	63.46%	65.42%	56.08%	82.08%	78.60%	51.16%	28.24%	-

Revenue by Geography

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
UNITED STATES	116.58M	151.36M	195.3M	246.28M	316.14M	419.16M	580.97M	764.35M	935.31M	1.07B
UNITED STATES Growth	-	29.83%	29.03%	26.11%	28.37%	32.59%	38.60%	31.57%	22.37%	14.74%
CANADA	30.38M	36.87M	47.37M	57.68M	67.8M	82.87M	118.03M	140.83M	173.29M	212.53M
CANADA Growth	-	21.37%	28.48%	21.76%	17.55%	22.22%	42.43%	19.32%	23.05%	22.64%

Frequently Asked Questions

Growth & Financials

Trupanion, Inc. (TRUP) grew revenue by 16.0% over the past year. This is strong growth.

Yes, Trupanion, Inc. (TRUP) is profitable, generating $15.5M in net income for fiscal year 2024 (-0.7% net margin).

Dividend & Returns

Trupanion, Inc. (TRUP) has a return on equity (ROE) of -3.1%. Negative ROE indicates the company is unprofitable.

Industry Metrics

Trupanion, Inc. (TRUP) has a combined ratio of 100.7%. A ratio above 100% means claims and expenses exceed premiums.

US Stock Screener

...

Trupanion, Inc. (TRUP) 10-Year Financial Performance & Capital Metrics

TRUP • • Insurance & Managed Care

Financial ServicesSpecialty InsuranceSpecialty Property & Casualty InsurancePet Insurance Providers

Revenue $1.29B +16.0%
Combined Ratio 100.74% -2.8%
Net Income -$10M +78.4%
Return on Equity -3.07% +79.1%
Medical Cost Ratio 86.09% -2.4%
Operating Margin -0.74% +79.8%
Net Margin -0.75% +81.4%
ROA -1.21% +80.3%
Equity / Assets 40.07% +3.3%
Book Value per Share 7.67 +4.6%
Tangible BV/Share 6.48 +11.3%
Debt/Equity 0.40 -6.1%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong Piotroski F-Score: 7/9

✗Weaknesses

✗Weak momentum: RS Rating 19 (bottom 19%)
✗High loss ratio of 86.1%
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y27.2%

5Y27.34%

3Y22.52%

TTM12.5%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM214.92%

EPS CAGR

10Y-

5Y-

3Y-

TTM211.27%

ROCE

10Y Avg-8.39%

5Y Avg-7.23%

3Y Avg-7.99%

Latest-2.12%

Peer Comparison

Pet Insurance Providers

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
TRUPTrupanion, Inc.	1.46B	33.91	-147.43	15.97%	1.1%	4.19%	2.63%	0.40

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Revenue+	146.96M	188.23M	242.67M	303.96M	383.94M	502.03M	698.99M	905.18M	1.11B	1.29B
Revenue Growth %	0.27%	0.28%	0.29%	0.25%	0.26%	0.31%	0.39%	0.29%	0.22%	0.16%
Medical Costs & Claims+	121.73M	154.94M	199.62M	252.59M	319.01M	420.13M	594.64M	782.99M	977.59M	1.11B
Medical Cost Ratio %	-	-	-	-	-	-	-	-	-	-
Gross Profit+	25.23M	33.29M	43.05M	51.37M	64.92M	81.9M	104.35M	122.19M	131.02M	178.8M
Gross Margin %	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	0.27%	0.32%	0.29%	0.19%	0.26%	0.26%	0.27%	0.17%	0.07%	0.36%
Operating Expenses+	42M	39.99M	45.69M	52.41M	66.84M	86.83M	139.54M	165.19M	171.68M	188.31M
OpEx / Revenue %	-	-	-	-	-	-	-	-	-	-
Depreciation & Amortization	2.54M	3.85M	4.23M	4.51M	5.63M	7.07M	11.96M	10.92M	12.47M	16.47M
Combined Ratio %	-	-	-	-	-	-	-	-	-	-
Operating Income+	-16.77M	-6.7M	-2.64M	-1.04M	-1.92M	-4.93M	-35.2M	-43M	-40.66M	-9.51M
Operating Margin %	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	-0.05%	0.6%	0.61%	0.6%	-0.84%	-1.57%	-6.14%	-0.22%	0.05%	0.77%
EBITDA+	-14.23M	-2.85M	1.59M	3.47M	3.71M	2.14M	-23.23M	-32.08M	-28.18M	6.95M
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-
Interest Expense	325K	218K	533K	1.2M	1.35M	1.38M	10K	4.27M	12.08M	14.5M
Non-Operating Income	-9K	-58K	-1.24M	-1.31M	-1.63M	-581K	14K	-3.07M	-7.7M	-14.37M
Pretax Income+	-17.09M	-6.86M	-1.93M	-934K	-1.64M	-5.73M	-35.22M	-44.2M	-45.03M	-9.64M
Pretax Margin %	-	-	-	-	-	-	-	-	-	-
Income Tax+	114K	38K	-428K	-7K	169K	113K	310K	476K	-342K	-5K
Effective Tax Rate %	-	-	-	-	-	-	-	-	-	-
Net Income+	-17.2M	-6.9M	-1.5M	-927K	-1.81M	-5.84M	-35.53M	-44.67M	-44.69M	-9.63M
Net Margin %	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	0.19%	0.6%	0.78%	0.38%	-0.95%	-2.23%	-5.08%	-0.26%	-0%	0.78%
EPS (Diluted)+	-0.62	-0.24	-0.05	-0.03	-0.05	-0.16	-0.89	-1.10	-1.08	-0.23
EPS Growth %	0.18%	0.61%	0.79%	0.43%	-0.8%	-2.07%	-4.56%	-0.24%	0.02%	0.79%
EPS (Basic)	-0.62	-0.24	-0.05	-0.03	-0.05	-0.16	-0.89	-1.10	-1.08	-0.23
Diluted Shares Outstanding	27.64M	28.53M	29.59M	31.96M	34.65M	35.86M	40.14M	40.77M	41.44M	42.16M

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Assets+	70.92M	82.34M	105.86M	207.51M	257.2M	498.25M	562.58M	671.63M	782.95M	806.85M
Asset Growth %	-0.28%	0.16%	0.29%	0.96%	0.24%	0.94%	0.13%	0.19%	0.17%	0.03%
Total Investment Assets+	27.98M	32.42M	40.83M	58.11M	74.06M	95.43M	133.07M	164.65M	142.53M	147.46M
Long-Term Investments	2.69M	2.85M	3.24M	3.55M	4.32M	5.57M	7.06M	7.84M	12.87M	373K
Short-Term Investments	25.29M	29.57M	37.59M	54.56M	69.73M	89.86M	126.01M	156.8M	129.67M	147.09M
Total Current Assets+	53.63M	65.39M	86.56M	117.98M	158.82M	337.03M	390.95M	469.1M	562.09M	597.33M
Cash & Equivalents	17.96M	23.64M	25.71M	26.55M	29.17M	139.88M	87.4M	65.61M	147.5M	160.29M
Receivables	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Assets	0	0	0	0	0	0	0	14.25M	17.02M	15.91M
Goodwill & Intangibles+	4.85M	4.91M	4.97M	8.07M	7.73M	60.18M	55.37M	66.01M	62.46M	50.15M
Goodwill	0	0	0	0	0	33.05M	32.71M	41.98M	43.71M	36.97M
Intangible Assets	4.85M	4.91M	4.97M	8.07M	7.73M	27.13M	22.66M	24.03M	18.75M	13.18M
PP&E (Net)	9.72M	8.46M	7.87M	69.8M	70.37M	72.6M	77.95M	90.7M	103.65M	102.19M
Other Assets	23K	734K	3.22M	8.11M	15.95M	22.88M	31.25M	37.98M	41.88M	56.81M
Total Liabilities	25.56M	37.63M	57.42M	78.34M	120.44M	158.31M	230.38M	366.33M	479.23M	483.58M
Total Debt+	0	4.77M	9.32M	12.86M	26.09M	0	0	69.46M	128.93M	128.89M
Net Debt	-17.96M	-18.87M	-16.38M	-13.69M	-3.08M	-139.88M	-87.4M	3.85M	-18.57M	-31.41M
Long-Term Debt	0	4.77M	9.32M	12.86M	26.09M	0	0	68.35M	127.58M	127.54M
Short-Term Debt	0	0	0	0	0	0	0	1.1M	1.35M	1.35M
Total Current Liabilities+	23.62M	30.66M	45.87M	63.2M	91.63M	150.4M	223.7M	289.62M	344.47M	349.63M
Accounts Payable	1.29M	2.01M	2.72M	2.77M	4.09M	6.06M	8.95M	9.47M	10.51M	11.53M
Deferred Revenue	11.04M	13.46M	22.73M	33.03M	52.55M	92.55M	146.91M	202.69M	235.33M	251.64M
Other Current Liabilities	6.44M	-20.89M	12.76M	16.06M	21.19M	28.93M	39.67M	43.73M	63.24M	85.1M
Deferred Taxes	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Liabilities	1.77M	32.61M	1.23M	1.27M	1.61M	3.21M	3.86M	4.97M	4.49M	4.48M
Total Equity+	45.36M	44.72M	48.43M	129.17M	136.76M	339.94M	332.2M	305.3M	303.72M	323.27M
Equity Growth %	-0.23%	-0.01%	0.08%	1.67%	0.06%	1.49%	-0.02%	-0.08%	-0.01%	0.06%
Shareholders Equity	45.36M	44.72M	48.43M	129.17M	136.76M	339.94M	332.2M	305.3M	303.72M	323.27M
Minority Interest	0	0	0	0	0	0	0	0	0	0
Retained Earnings	-74.39M	-81.28M	-82.78M	-83.71M	-85.52M	-91.36M	-126.89M	-171.56M	-216.25M	-225.89M
Common Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-502K	-377K	-92K	-753K	250K	3.07M	3.08M	-6.3M	403K	-2.61M
Return on Equity (ROE)	-0.33%	-0.15%	-0.03%	-0.01%	-0.01%	-0.02%	-0.11%	-0.14%	-0.15%	-0.03%
Return on Assets (ROA)	-0.2%	-0.09%	-0.02%	-0.01%	-0.01%	-0.02%	-0.07%	-0.07%	-0.06%	-0.01%
Equity / Assets	-	-	-	-	-	-	-	-	-	-
Debt / Equity	-	0.11x	0.19x	0.10x	0.19x	-	-	0.23x	0.42x	0.40x
Book Value per Share	1.64	1.57	1.64	4.04	3.95	9.48	8.28	7.49	7.33	7.67
Tangible BV per Share	-	-	-	-	-	-	-	-	-	-

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-10.43M	5.01M	9.67M	12.68M	16.16M	21.54M	7.46M	-8M	18.64M	48.29M
Operating CF Growth %	0.03%	1.48%	0.93%	0.31%	0.27%	0.33%	-0.65%	-2.07%	3.33%	1.59%
Operating CF / Revenue %	-	-	-	-	-	-	-	-	-	-
Net Income	-17.2M	-6.9M	-1.5M	-927K	-1.81M	-5.84M	-35.53M	-44.67M	-44.69M	-9.63M
Depreciation & Amortization	2.54M	3.85M	4.23M	4.51M	5.63M	7.07M	11.96M	10.92M	12.47M	16.47M
Stock-Based Compensation	3M	2.95M	3.42M	4.78M	6.85M	8.91M	28.23M	33.39M	33.16M	33.43M
Deferred Taxes	0	0	-1.04M	0	0	0	0	0	0	0
Other Non-Cash Items	-68K	104K	-383K	-240K	105K	153K	-1.93M	1.05M	1.35M	3.55M
Working Capital Changes	1.3M	5.01M	4.94M	4.56M	5.38M	11.25M	4.72M	-8.69M	16.35M	4.47M
Cash from Investing+	-9.92M	-6.51M	-13.06M	-81.45M	-28.01M	-76.75M	-51.91M	-67.52M	7.64M	-13.46M
Capital Expenditures	-4.89M	-1.94M	-3.13M	-59.9M	-5.37M	-7.45M	-12.36M	-17.09M	-18.28M	-9.72M
Acquisitions	-300K	0	1.4M	2.96M	0	-48.13M	0	-15.03M	0	0
Purchase of Investments	-24.8M	-31.62M	-31.92M	-55.86M	-69.51M	-65.29M	-95.67M	-273.01M	-165.94M	-133.49M
Sale/Maturity of Investments	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Investing	-109K	-198K	-2.78M	-4.07M	-2.89M	57K	-1.75M	-1.6M	1.58M	2.1M
Cash from Financing+	-14.21M	7.67M	5.08M	71.23M	14.04M	170.85M	-1.13M	60.74M	59.13M	-3.96M
Dividends Paid	0	0	0	0	0	0	0	-6.94M	0	0
Share Repurchases	-643K	-662K	-1.17M	-1.84M	-1.67M	-1.11M	-4.73M	-5.75M	-1.54M	-2.52M
Stock Issued	1.33M	0	0	65.67M	0	192.26M	3.61M	0	0	0
Debt Issuance (Net)	-1000K	1000K	1000K	1000K	1000K	-1000K	0	1000K	1000K	-1000K
Other Financing	692K	3.35M	1.85M	3.97M	2.54M	5.93M	0	9.23M	2.28M	-88K
Net Change in Cash+	-35.14M	6.28M	2.07M	1.65M	2.62M	115.63M	-45.33M	-16.23M	85.83M	29.07M
Exchange Rate Effect	-586K	111K	378K	-812K	423K	-16K	252K	-1000K	424K	-1000K
Cash at Beginning	53.1M	17.96M	24.24M	26.31M	27.95M	30.57M	146.2M	100.87M	84.64M	170.46M
Cash at End	17.96M	24.24M	26.31M	27.95M	30.57M	146.2M	100.87M	84.64M	170.46M	199.53M
Free Cash Flow+	-15.32M	3.06M	6.54M	-47.22M	10.78M	14.09M	-4.9M	-25.09M	358K	38.57M
FCF Growth %	0.07%	1.2%	1.13%	-8.22%	1.23%	0.31%	-1.35%	-4.12%	1.01%	106.74%
FCF Margin %	-	-	-	-	-	-	-	-	-	-
FCF per Share	-0.55	0.11	0.22	-1.48	0.31	0.39	-0.12	-0.62	0.01	0.91

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Combined Ratio	111.41%	103.56%	101.09%	100.34%	100.5%	100.98%	105.04%	104.75%	103.67%	100.74%
Medical Cost Ratio	82.83%	82.32%	82.26%	83.1%	83.09%	83.69%	85.07%	86.5%	88.18%	86.09%
Return on Equity (ROE)	-32.89%	-15.31%	-3.23%	-1.04%	-1.36%	-2.45%	-10.57%	-14.01%	-14.68%	-3.07%
Return on Assets (ROA)	-20.33%	-9%	-1.6%	-0.59%	-0.78%	-1.55%	-6.7%	-7.24%	-6.15%	-1.21%
Equity / Assets	63.96%	54.3%	45.75%	62.25%	53.17%	68.23%	59.05%	45.46%	38.79%	40.07%
Book Value / Share	1.64	1.57	1.64	4.04	3.95	9.48	8.28	7.49	7.33	7.67
Debt / Equity	-	0.11x	0.19x	0.10x	0.19x	-	-	0.23x	0.42x	0.40x
Revenue Growth	26.79%	28.08%	28.92%	25.26%	26.31%	30.76%	39.23%	29.5%	22.47%	15.97%

Revenue by Segment

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Subscription business	133.41M	173.36M	218.35M	263.74M	321.16M	387.73M	494.86M	596.61M	712.91M	856.52M
Subscription business Growth	-	29.95%	25.96%	20.78%	21.77%	20.73%	27.63%	20.56%	19.49%	20.15%
Other Operating	-	-	-	-	-	-	-	-	-	429.16M
Other Operating Growth	-	-	-	-	-	-	-	-	-	-
Others	13.56M	14.87M	24.31M	40.22M	62.77M	114.3M	204.13M	308.57M	395.7M	-
Others Growth	-	9.71%	63.46%	65.42%	56.08%	82.08%	78.60%	51.16%	28.24%	-

Revenue by Geography

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
UNITED STATES	116.58M	151.36M	195.3M	246.28M	316.14M	419.16M	580.97M	764.35M	935.31M	1.07B
UNITED STATES Growth	-	29.83%	29.03%	26.11%	28.37%	32.59%	38.60%	31.57%	22.37%	14.74%
CANADA	30.38M	36.87M	47.37M	57.68M	67.8M	82.87M	118.03M	140.83M	173.29M	212.53M
CANADA Growth	-	21.37%	28.48%	21.76%	17.55%	22.22%	42.43%	19.32%	23.05%	22.64%

Frequently Asked Questions

Growth & Financials

Trupanion, Inc. (TRUP) grew revenue by 16.0% over the past year. This is strong growth.

Yes, Trupanion, Inc. (TRUP) is profitable, generating $15.5M in net income for fiscal year 2024 (-0.7% net margin).

Dividend & Returns

Trupanion, Inc. (TRUP) has a return on equity (ROE) of -3.1%. Negative ROE indicates the company is unprofitable.

Industry Metrics

Trupanion, Inc. (TRUP) has a combined ratio of 100.7%. A ratio above 100% means claims and expenses exceed premiums.